Some patients recognize no words at all 12 months after surgery, while others essentially have normal hearing in our analysis. This wide range of speech perception outcomes, we conclude, translates into considerable uncertainty for patients.
Boston Scientific's neurostimulation device Vercise is built on cochlear implant technology, allowing it to modulate impulses between multiple contacts.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
The collaboration with Cochlear Ltd. is an example of how Apple has been ramping up its medtech profile.
What's called a Versatile Extra-Sensory Transducer could be a non-invasive, less expensive alternative to the cochlear implant for deaf people.